Orgenesis Inc. Profile Avatar - Palmy Investing

Orgenesis Inc.

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare t…

Biotechnology
US, Germantown [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Orgenesis Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Orgenesis Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Orgenesis Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of ORGS's Analysis
CIK: 1460602 CUSIP: 68619K204 ISIN: US68619K2042 LEI: - UEI: -
Secondary Listings
ORGS has no secondary listings inside our databases.